A Decade of Bulevirtide Use in Chronic Hepatitis Delta: Real-World Clinical Results
Bulevirtide is a safe and effective treatment for chronic hepatitis delta in a real-world clinical setting. These findings support its role as a sustainable therapeutic option for patients with HDV infection.
Authors
- Stephan A. Schmid (ORCID: https://orcid.org/0000-0003-2222-2926)
- Sophia Rusch
- Petra Stöckert
- Tobias Schilling (ORCID: https://orcid.org/0000-0003-1715-6143)
- Martina Müller
Institutions
- University Hospital Regensburg (DE)
- Klinikum Stuttgart (DE)
Publication Details
- Journal
- Journal of Gastrointestinal and Liver Diseases
- Published
- 2025-12-26
- DOI
- https://doi.org/10.15403/jgld-6501
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Universitätsklinikum Regensburg